Patents Assigned to Nelson Research & Development Company
  • Cosmetic use of cyclic AMP and phosphodiesterase inhibitors
    Patent number: 3978213
    Abstract: Methods and compositions designed for dermatological and cosmetic use containing as an active ingredient, cyclic 3',5'-adenosine monophosphate and salts thereof and optionally, a phosphodiesterase inhibitor such as theophylline.
    Type: Grant
    Filed: January 3, 1975
    Date of Patent: August 31, 1976
    Assignee: Nelson Research & Development Company
    Inventors: Eugene Lapinet, Georges D. Cehovic, Theodore Z. Posternak
  • Composition and method for treatment of acne
    Patent number: 3969516
    Abstract: There is disclosed a method for topical treatment of acne. The method involves topical treatment of a human suffering from acne with an effective amount of an antibiotic of the lincomycin family.
    Type: Grant
    Filed: July 7, 1975
    Date of Patent: July 13, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Richard B. Stoughton
  • Antidepressant
    Patent number: 3961073
    Abstract: A method for treating depression in humans by administering to depressed humans a composition containing an effective amount of the (-) enantiomer of trans-2-phenylcyclopropylamine or a pharmaceutically acceptable acid addition salt thereof, said composition being substantially free of (+) trans-2-phenylcyclopropylamine.
    Type: Grant
    Filed: July 1, 1975
    Date of Patent: June 1, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Solomon H. Snyder
  • Topical anti-inflammatory composition and method of use
    Patent number: 3957994
    Abstract: There is disclosed a novel topical anti-inflammatory composition comprising theophylline and 2-pyrrolidone or an N-lower alkyl-2-pyrrolidone.
    Type: Grant
    Filed: December 19, 1974
    Date of Patent: May 18, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Richard Allen Schroer
  • Method and composition for potentiating neuroleptic drugs
    Patent number: 3947579
    Abstract: A method and composition for potentiating the effects of neuroleptic drugs by administering to a human having a disorder normally treatable with a neuroleptic drug, a neuroleptic drug in combination with a potentiating amount of an amino acid of the formula ##SPC1##Where R is fluorine, chlorine, bromine or trifluoromethyl and their salts.
    Type: Grant
    Filed: June 3, 1974
    Date of Patent: March 30, 1976
    Assignee: Nelson Research & Development Company
    Inventor: Kjell Fuxe